AA

ALPS Advisors Portfolio holdings

AUM $17.3B
1-Year Est. Return 13.43%
This Quarter Est. Return
1 Year Est. Return
+13.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.3B
AUM Growth
+$91.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,066
New
Increased
Reduced
Closed

Top Buys

1 +$100M
2 +$99.4M
3 +$41.5M
4
WES icon
Western Midstream Partners
WES
+$32.9M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$28.1M

Sector Composition

1 Energy 68.28%
2 Technology 4.29%
3 Financials 3.4%
4 Consumer Discretionary 2.95%
5 Materials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRMR icon
1026
Larimar Therapeutics
LRMR
$365M
-47,460
MAG
1027
DELISTED
MAG Silver
MAG
-392,675
MGNX icon
1028
MacroGenics
MGNX
$107M
-48,646
MLYS icon
1029
Mineralys Therapeutics
MLYS
$3.33B
-34,664
NAK
1030
Northern Dynasty Minerals
NAK
$1.24B
-1,308,007
NMRA icon
1031
Neumora Therapeutics
NMRA
$288M
-114,371
NTLA icon
1032
Intellia Therapeutics
NTLA
$2.67B
-77,328
PLD icon
1033
Prologis
PLD
$113B
-3,809
PLL
1034
DELISTED
Piedmont Lithium
PLL
-33,637
PLRX icon
1035
Pliant Therapeutics
PLRX
$101M
-45,261
PROK icon
1036
ProKidney
PROK
$410M
-95,182
RIGL icon
1037
Rigel Pharmaceuticals
RIGL
$504M
-13,100
RNAC icon
1038
Cartesian Therapeutics
RNAC
$245M
-19,392
SLRN
1039
DELISTED
ACELYRIN
SLRN
-74,640
STRO icon
1040
Sutro Biopharma
STRO
$74.7M
-61,267
SVRA icon
1041
Savara
SVRA
$619M
-115,752
VRNA
1042
DELISTED
Verona Pharma
VRNA
-60,180
WOLF icon
1043
Wolfspeed
WOLF
$838M
-242,648
ZNTL icon
1044
Zentalis Pharmaceuticals
ZNTL
$113M
-55,033
AVBP icon
1045
ArriVent BioPharma
AVBP
$796M
-25,167
KYTX icon
1046
Kyverna Therapeutics
KYTX
$303M
-32,126
FBMS
1047
DELISTED
The First Bancshares, Inc.
FBMS
-10,330
ML
1048
DELISTED
MoneyLion Inc.
ML
-4,130
ACRS icon
1049
Aclaris Therapeutics
ACRS
$222M
-78,782
ALDX icon
1050
Aldeyra Therapeutics
ALDX
$324M
-43,803